2026. Molecularly Modified Benzimidazole Derivatives: Rational Design and Antimicrobial Potentials for Next-Generation Therapeutics. Current Pharmaceutical Letters And Reviews. 2, 1 (Jan. 2026), 01–19. DOI:https://doi.org/10.62896/cplr.3.1.01.